Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab.
Pasello G, Lorenzi M, Calvetti L, Oliani C, Pavan A, Favaretto A, Palazzolo G, Giovanis P, Zustovich F, Bonetti A, Bernardi D, Mandarà M, Aprile G, Crivellaro G, Sinigaglia G, Tognazzo S, Morandi P, Bortolami A, Marino V, Bonanno L, Guarneri V, Conte P.
Pasello G, et al. Among authors: crivellaro g.
Oncologist. 2022 Jun 8;27(6):e484-e493. doi: 10.1093/oncolo/oyac051.
Oncologist. 2022.
PMID: 35429394
Free PMC article.